AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

WeWork data shows growth still doubling By Reuters

2019-11-08

© Reuters. FILE PHOTO: WeWork offices in San Francisco By Herbert Lash NEW YORK (Reuters) – WeWork owner The We Company disclosed data on Friday that showed expansion of its office-sharing business was almost doubling in size from a large pipeline of leases even as the money-losing company plans toRead More →